Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum

NCT00527111 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT00527111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00527111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
January 31, 2015
Enrollment
139 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer